JP2017193591A5 - - Google Patents

Download PDF

Info

Publication number
JP2017193591A5
JP2017193591A5 JP2017151484A JP2017151484A JP2017193591A5 JP 2017193591 A5 JP2017193591 A5 JP 2017193591A5 JP 2017151484 A JP2017151484 A JP 2017151484A JP 2017151484 A JP2017151484 A JP 2017151484A JP 2017193591 A5 JP2017193591 A5 JP 2017193591A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017151484A
Other versions
JP2017193591A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017193591A publication Critical patent/JP2017193591A/ja
Publication of JP2017193591A5 publication Critical patent/JP2017193591A5/ja
Pending legal-status Critical Current

Links

JP2017151484A 2012-05-23 2017-08-04 腫瘍細胞選択的抗がん剤 Pending JP2017193591A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012117205 2012-05-23
JP2012117205 2012-05-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013106793A Division JP2014001204A (ja) 2012-05-23 2013-05-21 腫瘍細胞選択的抗がん剤

Publications (2)

Publication Number Publication Date
JP2017193591A JP2017193591A (ja) 2017-10-26
JP2017193591A5 true JP2017193591A5 (ja) 2017-12-07

Family

ID=50034731

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013106793A Pending JP2014001204A (ja) 2012-05-23 2013-05-21 腫瘍細胞選択的抗がん剤
JP2017151484A Pending JP2017193591A (ja) 2012-05-23 2017-08-04 腫瘍細胞選択的抗がん剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013106793A Pending JP2014001204A (ja) 2012-05-23 2013-05-21 腫瘍細胞選択的抗がん剤

Country Status (1)

Country Link
JP (2) JP2014001204A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI662895B (zh) * 2015-11-30 2019-06-21 日商大日本除蟲菊股份有限公司 粉末狀害蟲忌避組成物之用途及其製造方法
JP2020535235A (ja) * 2017-09-28 2020-12-03 アスデラ エルエルシー リン脂質の調節異常が関与する疾患および障害におけるシクロデキストリンの使用
EP4378465A1 (en) 2021-07-30 2024-06-05 Saga University Pharmaceutical composition for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007339918B2 (en) * 2006-12-29 2011-06-02 Tracon Pharmaceuticals, Inc. Antifolate agent combinations in the treatment of cancer
EA017017B1 (ru) * 2007-08-02 2012-09-28 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Окисленный авидин с большим временем удержания в обработанной им ткани
EP2194068B1 (en) * 2007-09-28 2013-04-17 Nanodex INC. Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
US7863255B2 (en) * 2008-04-29 2011-01-04 Taiho Pharmaceutical Co., Ltd. Methods of administering antitumor agent comprising deoxycytidine derivative
WO2010048330A1 (en) * 2008-10-21 2010-04-29 Threshold Pharmaceuticals, Inc. Treatment of cancer using hypoxia activated prodrugs
JP2011079788A (ja) * 2009-10-08 2011-04-21 Oita Univ 膵癌に対する選択的膵動脈制癌剤注入療法と全身化学療法との併用療法、およびそれに使用する膵癌治療薬

Similar Documents

Publication Publication Date Title
BR122021000189A2 (ja)
JP2017193591A5 (ja)
BR112019008823A2 (ja)
BR112020006084A8 (ja)
BR122021014832A2 (ja)
BR202018014992U2 (ja)
BR112020008820A2 (ja)
BR202017025154U2 (ja)
BR102017023327A2 (ja)
BR202017021228U2 (ja)
BR202017020981U2 (ja)
BR202017017068U2 (ja)
BR202017016984U2 (ja)
BR202017016924U2 (ja)
BR102017015495A2 (ja)
BR202017012548U2 (ja)
BR202017011220U2 (ja)
BR202017010814U2 (ja)
BR202017010373U2 (ja)
BR202017009870U2 (ja)
BR202017006953U2 (ja)
CN304005571S (ja)
CN303995367S (ja)
CN303991336S (ja)
CN303991096S (ja)